Under the agreement, Trinean obtained a license for the design and development of microfluidic cartridges and instruments in the field of UV/VIS quantification of lightabsorbing substances for certain life sciences research applications.
“We are very pleased with this agreement between PerkinElmer and Trinean. The combined IP from Trinean and PerkinElmer will boost the expansion of our platform for DNA, RNA and protein quantification and quality control," said Philippe Stas, CEO of Trinean. "Our microfluidic chips generate high quality UV/Vis spectral absorbance profiles of bio-molecules. They are designed to meet the requirements of labs requiring speed and minimal sample usage. Our unmatched large measurement range allows quantification of undiluted protein samples in real-time thereby significantly shortening the purification process.”
"The use of microfluidics for UV/Vis spectrometry is an exciting market development," said Kevin Hrusovsky, Life Sciences President, PerkinElmer. "We continue to leverage our microfluidics portfolio through licensing collaborations such as our agreement with Trinean to extend our market reach and create additional revenue opportunities."